ResultsCNBC-TV18
Cohance Lifesciences Q2 net profit plunges 80%
Negative-22Company event
GreyOak summary
Cohance Lifesciences reported a 79.5% drop in Q2 net profit to ₹15.2 crore, driven by a 14.2% revenue decline to ₹477 crore. EBITDA fell 93.2% to ₹35.7 crore due to an unfavorable product mix. The company expects a material recovery in the second half of FY27 supported by new orders and improved business mix.
What it affects
- Cohance LifesciencesCOHANCENegative -22
Net profit plunged 80% on lower revenueRolling sentiment Negative -54
Source
Read the original at CNBC-TV18More Cohance Lifesciences news
- Cohance Lifesciences Q2 Review: Brokerages Maintain Mixed ViewsNDTV Profit · Results ·
- Stocks to Watch Today: Tata Steel, Data Patterns, Voltas, Aster DM, GE Shipping, Gland, AnMoneycontrol · Stock view ·
- Cohance Lifesciences site shut after worker dies in accidentBusinessLine · Regulatory ·
- Cohance Life down 3% on plant closure; Thermax falls 14% on earnings missMoneycontrol · Results ·